Registered number
09345247
VRINDA PHARMA LTD
Filleted Accounts
31 December 2025

VRINDA PHARMA LTD
Registered number: | 09345247
Balance Sheet
as at 31 December 2025
Notes |  |  | 2025 |  |  | 2024
£ | £
Fixed assets
Tangible assets | 3 |  |  | 1,185 |  |  | 1,529
Current assets
Debtors | 4 |  | - |  |  | 4,200
Cash at bank and in hand |  |  | 10,010 |  |  | 10,683
|  |  | 10,010 |  |  | 14,883
Creditors: amounts falling due within one year | 5 |  | (9,271) |  |  | (10,633)
Net current assets |  |  |  | 739 |  |  | 4,250
Total assets less current liabilities |  |  |  | 1,924 |  |  | 5,779
Creditors: amounts falling due after more than one year | 6 |  |  | (1,989) |  |  | (4,853)
Net (liabilities)/assets |  |  |  | (65) |  |  | 926
Capital and reserves
Called up share capital |  |  |  | 1 |  |  | 1
Profit and loss account |  |  |  | (66) |  |  | 925
Shareholder's funds |  |  |  | (65) |  |  | 926
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Chiranjeevi Tupakula
Director
Approved by the board on 26 June 2026

VRINDA PHARMA LTD
Notes to the Accounts
for the year ended 31 December 2025
1 | Accounting policies
| Basis of preparation
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
| Turnover
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
| Tangible fixed assets
| Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
| Plant and machinery | over 5 years
| Fixtures, fittings, tools and equipment | over 5 years
| Debtors
| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
| Creditors
| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2 | Employees | 2025 |  | 2024
Number | Number
| Average number of persons employed by the company | 1 |  | 1
3 | Tangible fixed assets
|  |  |  |  |  |  |  | Plant and machinery etc
£
| Cost
| At 1 January 2025 | 4,887
| At 31 December 2025 | 4,887
| Depreciation
| At 1 January 2025 | 3,358
| Charge for the year | 344
| At 31 December 2025 | 3,702
| Net book value
| At 31 December 2025 | 1,185
| At 31 December 2024 | 1,529
4 | Debtors | 2025 |  | 2024
£ | £
| Other debtors | - |  | 4,200
5 | Creditors: amounts falling due within one year | 2025 |  | 2024
£ | £
| Taxation and social security costs | 9,231 |  | 9,612
| Other creditors | 40 |  | 1,021
|  |  |  |  |  | 9,271 |  | 10,633
6 | Creditors: amounts falling due after one year | 2025 |  | 2024
£ | £
| Bank loans | 1,989 |  | 4,853
7 | Controlling party
| The company is controlled by Mr Chiranjeevi Tupakula by virtue of his 100% share holding in the company.
8 | Other information
| VRINDA PHARMA LTD is a private company limited by shares and incorporated in England. Its registered office is:
| 25 Southend Road
| London
| England
| United Kingdom
| E6 2AL

VRINDA PHARMA LTD 09345247 false 2025-01-01 2025-12-31 2025-12-31 VT Final Accounts November 2025 Mr Chiranjeevi Tupakula No description of principal activity 09345247 2024-01-01 2024-12-31 09345247 core:WithinOneYear 2024-12-31 09345247 core:AfterOneYear 2024-12-31 09345247 core:ShareCapital 2024-12-31 09345247 core:RetainedEarningsAccumulatedLosses 2024-12-31 09345247 2025-01-01 2025-12-31 09345247 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 09345247 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 09345247 bus:Director40 2025-01-01 2025-12-31 09345247 1 2025-01-01 2025-12-31 09345247 2 2025-01-01 2025-12-31 09345247 core:PlantMachinery 2025-01-01 2025-12-31 09345247 countries:England 2025-01-01 2025-12-31 09345247 bus:FRS102 2025-01-01 2025-12-31 09345247 bus:FilletedAccounts 2025-01-01 2025-12-31 09345247 2025-12-31 09345247 core:WithinOneYear 2025-12-31 09345247 core:AfterOneYear 2025-12-31 09345247 core:ShareCapital 2025-12-31 09345247 core:RetainedEarningsAccumulatedLosses 2025-12-31 09345247 core:PlantMachinery 2025-12-31 09345247 2024-12-31 09345247 core:PlantMachinery 2024-12-31 iso4217:GBP xbrli:pure